Malignant ovarian germ cell tumors: A single-institution experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 2, 2009, Pages 191-196

  Cicin, Irfan ^a   Eralp, Yesim ^b   Saip, Pinar ^b   Ayan, Inci ^c   Kebudi, Rejin ^c   Iyibozkurt, Cem ^c   Tuzlali, Sitki ^d   Gorgun, Omer ^c   Topuz, Erkan ^b  

^a TRAKYA UNIVERSITY   (Turkey)

^b Department of Medical Oncology ^*

^c Institute of Oncology   (Turkey)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Fertility; Immunosuppression; Ovarian germ cell tumor; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; PREDNISONE; VINBLASTINE; VINCRISTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHILD; CHORIOCARCINOMA; CLINICAL FEATURE; CONCEPTION; CYSTECTOMY; DELIVERY; DRUG FATALITY; DYSGERMINOMA; EMBRYONAL CARCINOMA; FEMALE; FEMALE FERTILITY; FOLLOW UP; GERM CELL TUMOR; GONADOBLASTOMA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENSTRUATION; MIXED TUMOR; MULTIPLE CYCLE TREATMENT; OVARY TUMOR; PELVIS; PERITONEAL CAVITY; PROGNOSIS; SALPINGOOOPHORECTOMY; SCHOOL CHILD; SCLERODERMA; SEX CORD TUMOR; SURVIVAL RATE; TERATOMA; THERAPY EFFECT; TUMOR RECURRENCE; YOLK SAC TUMOR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67749148917     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181841f2e     Document Type: Article

References (24)

1. Mitchell PL, Al-Nasiri N, A'Hern R, et al. Treatment of nondysgerminoma-tous ovarian germ cell tumors: an analysis of 69 cases. Cancer. 1999;15: 2232-2244.
2. Tewari K, Cappuccini F, Disaia PJ, et al. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000;95:128-133.
3. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25:2938-2943.
4. Serov SF, Scully RE, Sobin LJ. Histological typing of ovarian tumors. In: World Health Organization. International Histological Classification of Tumors. Geneva: World Health Organization; 1973.
5. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37:2359-2372.
6. Staging Anouncement: FIGO Cancer Committee. Gynecol Oncol. 1986;25: 383.
7. Lai CH, Chang TC, Hsueh S, et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol Oncol. 2005;96:784-791.
8. Murugaesu N, Schmid P, Dancey G, et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol. 2006;24:4862-4866.
9. Fujita M, Inoue M, Tanizawa O, et al. Retrospective review of 41 patients with endodermal sinus tumor of the ovary. Int J Gynecol Cancer. 1993;3: 329-335.
10. Nawa A, Obata N, Kikkawa F, et al. Prognostic factors of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol. 2001;184:1182-1188.
11. Bower M, Fife K, Holden L, et al. Chemotherapy for ovarian germ cell tumours. Eur J Cancer. 1996;32:593-597.
12. Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer. 1976;38:2404-2419.
13. Low JJ, Perrin LC, Crandon AJ, et al. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer. 2000;89:391-398.
14. Gershenson DM, Miller AM, Champion VL, et al. Gynecologic Oncology Group. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:2792-2797.
15. Bakri YN, Ezzat A, Akhtar, et al. Malignant germ cell tumors of the ovary. Pregnancy considerations. Eur J Obstet Gynecol Reprod Biol. 2000;90: 87-91.
16. Motegi M, Takakura S, Takano H, et al. Adjuvant chemotherapy in a pregnant woman with endodermal sinus tumor of the ovary. Obstet Gynecol. 2007; 109:537-540.
17. Elit L, Bocking A, Kenyon C, et al. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol. 1999;72: 123-127.
18. Bonazzi C, Peccatori F, Colombo N, et al. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstet Gynecol. 1994;84:598-604.
19. Dark GG, Bower M, Newlands ES, et al. Surveillance policy for stage I ovarian germ cell tumors. J Clin Oncol. 1997;15:620-624.
20. Leibovitch I, Baniel J, Rowland RG, et al. Malignant testicular neoplasms in immunosuppressed patients. J Urol. 1996;155:1938-1942.
21. Powles T, Bower M, Daugaard G, et al. Multicenter study of human immunodeficiency virus-related germ cell tumors. J Clin Oncol. 2003;21: 1922-1927.
22. Hentrich MU, Brack NG, Schmid P, et al. Testicular germ cell tumors in patients with human immunodeficiency virus infection. Cancer. 1996;77: 2109-2116.
23. Lyter DW, Bryant J, Thackeray R, et al. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol. 1995;13:2540-2546.
24. Moodley M, Moodley J. Ovarian germ cell malignancy and human immunodeficiency virus (HIV) infection: a case report. Int J Gynecol Cancer. 2003;13:541-542.